William Blair Investment Management portfolio manager Jared Lou sits down with InvestmentNews anchor Gregg Greenberg in a recent video segment to explain why he believes emerging market debt looks attractive now.
Investment Management
Jared Lou joins InvestmentNews’ Segment “In the Nasdaq” to Discuss Emerging Markets Debt
Delivered to Your Inbox
Stay up-to-date with the latest William Blair news and insights
Our Latest News
-
Aardvark Therapeutics, Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Aardvark Therapeutics, Inc. (AARD $13.98). Aardvark is advancing ARD-101, an oral therapy that targets bitter taste receptors (TAS2Rs) in the gastrointestinal tract, and ARD-201, a combination of ARD-101 and a DPP-4 inhibitor, for treating Prader-Willi syndrome (PWS) and obesity, respectively.
-
-